|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006674,
umls-concept:C0028912,
umls-concept:C0036043,
umls-concept:C0065767,
umls-concept:C0205146,
umls-concept:C0205191,
umls-concept:C0221912,
umls-concept:C0392752,
umls-concept:C0406317,
umls-concept:C0524465,
umls-concept:C1707455
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-2-17
|
|
pubmed:abstractText |
Psoriasis involving sensitive skin areas remains difficult to treat because of the side-effects of topical corticosteroids and the irritancy potential of vitamin D3 derivatives. Several clinical trials have demonstrated that calcitriol, the naturally occurring and hormonally active form of vitamin D3, is effective and safe at the dose of 3 microg g(-1) for the treatment of psoriasis affecting the trunk and limbs.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0007-0963
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
148
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
326-33
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12588387-Adolescent,
pubmed-meshheading:12588387-Adult,
pubmed-meshheading:12588387-Aged,
pubmed-meshheading:12588387-Axilla,
pubmed-meshheading:12588387-Calcitriol,
pubmed-meshheading:12588387-Dermatologic Agents,
pubmed-meshheading:12588387-Double-Blind Method,
pubmed-meshheading:12588387-Drug Tolerance,
pubmed-meshheading:12588387-Ear, External,
pubmed-meshheading:12588387-Edema,
pubmed-meshheading:12588387-Erythema,
pubmed-meshheading:12588387-Facial Dermatoses,
pubmed-meshheading:12588387-Female,
pubmed-meshheading:12588387-Humans,
pubmed-meshheading:12588387-Male,
pubmed-meshheading:12588387-Middle Aged,
pubmed-meshheading:12588387-Ointments,
pubmed-meshheading:12588387-Patient Satisfaction,
pubmed-meshheading:12588387-Psoriasis,
pubmed-meshheading:12588387-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas.
|
|
pubmed:affiliation |
Hôpital de l'Archet 2, Nice, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
